Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system
Type
Public
HQ
Seattle, US
Employees
162 (est)
Omeros is headquartered in Seattle, US

Key People at Omeros

Timothy M. Duffy

Timothy M. Duffy

Vice President, Business Development
Gregory A. Demopulos

Gregory A. Demopulos

Chairman and Chief Executive Officer
Wayne Wager

Wayne Wager

Director

Omeros Locations

Seattle, US

Omeros Metrics

Omeros Summary

Market capitalization

$461 M

Closing share price

$11.1
Omeros's latest market capitalization is $461 M.

Omeros Market Value History

Omeros News

Omeros Company Life

You may also be interested in